EU to approve Pfizer vaccine contract tomorrow

The European Commission will approve a contract for the supply of the Covid-19 vaccine being developed by Pfizer and BioNTech tomorrow, its President Ursula von der Leyen said. The two companies said their experimental vaccine was more than 90% effective, in what could be a major victory in the fight against the coronavirus pandemic. Protection in patients was achieved seven days after the second of two doses, and 28 days after the first, according to preliminary findings on the Pfizer and BioNTech vaccine. 'Tomorrow we will authorise a contract for up to 300 million doses of the vaccine developed by German company BioNTech and Pfizer,' Ms von der Leyen said in a statement.